Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Shares Issued (2021 - 2024)

Historic Shares Issued for Kezar Life Sciences (KZR) over the last 4 years, with Q2 2024 value amounting to $56000.0.

  • Kezar Life Sciences' Shares Issued fell 9995.75% to $56000.0 in Q2 2024 from the same period last year, while for Sep 2025 it was $56000.0, marking a year-over-year decrease of 9995.75%. This contributed to the annual value of $103000.0 for FY2024, which is 8385.58% down from last year.
  • As of Q2 2024, Kezar Life Sciences' Shares Issued stood at $56000.0, which was down 9995.75% from $131.7 million recorded in Q4 2023.
  • Over the past 5 years, Kezar Life Sciences' Shares Issued peaked at $131.7 million during Q2 2023, and registered a low of $43000.0 during Q3 2023.
  • In the last 4 years, Kezar Life Sciences' Shares Issued had a median value of $282000.0 in 2021 and averaged $20.5 million.
  • Per our database at Business Quant, Kezar Life Sciences' Shares Issued skyrocketed by 3110853.08% in 2023 and then plummeted by 9995.75% in 2024.
  • Kezar Life Sciences' Shares Issued (Quarter) stood at $580000.0 in 2021, then decreased by 12.76% to $506000.0 in 2022, then skyrocketed by 25927.67% to $131.7 million in 2023, then tumbled by 99.96% to $56000.0 in 2024.
  • Its Shares Issued was $56000.0 in Q2 2024, compared to $131.7 million in Q4 2023 and $43000.0 in Q3 2023.